Cagkan Sayin/Adobe Stock

The Centers for Medicare & Medicaid Services has issued revised guidance for implementation of the new Medicare Drug Price Negotiation Program, perhaps in response to the four lawsuits challenging the program. The first round of negotiations will occur in 2023 and 2024, resulting in prices that will be effective beginning in 2026.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.